Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for IVF hartmann Holding AG's Net Cash per Share or its related term are showing as below:
XSWX:VBSN'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.43 Med: 25.34 Max: 153.92
Current: 4.47
During the past 13 years, the highest Price-to-Net-Cash Ratio of IVF hartmann Holding AG was 153.92. The lowest was 4.43. And the median was 25.34.
XSWX:VBSN's Price-to-Net-Cash is ranked better than 74.49% of 294
companies
in the Medical Devices & Instruments industry
Industry Median: 9.3
vs XSWX:VBSN: 4.47
IVF hartmann Holding AG (XSWX:VBSN) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
IVF hartmann Holding AG Net Cash per Share Related Terms
IVF hartmann Holding AG Net Cash per Share Historical Data
* Premium members only.
The historical data trend for IVF hartmann Holding AG's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:VBSN vs ISRG, BDX, RMD: Net Cash per Share Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Price-to-Net-Cash vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Price-to-Net-Cash falls into.
IVF hartmann Holding AG Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
IVF hartmann Holding AG's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a Net Cash per Share of CHF28.75 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on IVF hartmann Holding AG and its competitors. According to the industry distribution chart, IVF hartmann Holding AG ranks #75 out of 294 companies in the Medical Devices & Instruments industry, placing it in the top 25.5%.
Is IVF hartmann Holding AG's Net Cash per Share too high?
IVF hartmann Holding AG's current Net Cash per Share is CHF28.75. Based on the distribution chart, IVF hartmann Holding AG ranks #75 out of 294 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Net Cash per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #75 out of 294 companies for Net Cash per Share. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median Net Cash per Share is 9.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Devices & Instruments company?
The median Net Cash per Share among Medical Devices & Instruments companies is 9.30, based on 294 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Net Cash per Share is 9.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Net Cash per Share is CHF28.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF149.89, compared to a current price of CHF128.50 — trading 14.3% below its estimated fair value. The current Net Cash per Share is CHF28.75. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Net Cash per Share is CHF28.75 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF128.50 is trading 14.3% below its estimated GF Value™ of CHF149.89.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
Net Cash per Share: CHF28.75
GF Value™: CHF149.89 vs. price of CHF128.50 (14.3% below fair value)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
